MIM
NVO

Merrion Investment Management’s Novo Nordisk NVO Stock Holding History

Merrion Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938K Buy
+19,565
New +$841K 0.44% 49

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

Merrion Investment Management's NVO Position: Q2 2026 in Review

Merrion Investment Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 19,565 shares worth $938K. The stake represents 0.44% of the portfolio and ranks #49 among its holdings.

528 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Merrion Investment Management held 19,565 shares of Novo Nordisk worth $938K as of Q2 2026.
  • Novo Nordisk was a new Merrion Investment Management position in Q2 2026.
  • Novo Nordisk made up 0.44% of Merrion Investment Management's portfolio in Q2 2026, its #49 holding.
  • 528 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Merrion Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.